A redesigned immune-activating cancer drug has produced striking early results in a small clinical trial, shrinking tumors and sometimes eliminating them entirely.

Circuit Judge Lawrence Mirman, respected by colleagues, reflects on decades of public service as he prepares to retire.

A record-breaking collapse of U.S. honeybee colonies has stunned scientists and farmers alike. Behind the die-off lies a ...

From AI simulations to energy-efficient manufacturing, learn how leaders in academia and industry are conducting responsible, ...

The world once promised by liberal ideas and globalization is receding. As the Berlin Wall gives way to a European Drone Wall ...

Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial ...

Eco anxiety is very real, so we share this year's most uplifting stories to prove there’s hope for our climate. View on ...

Seattle Mariners center fielder Julio Rodriguez made a surprise visit at the Mercer Island Little League 20th anniversary ...

Medical experiments on research dogs could be phased out soon — a change that’s based as much on science as ethics. Pressure is coming from within the scientific community as well as from activists, ...

Comprehensive Analysis Examines Liposomal NMN Delivery, Dosage Research Context, Third-Party Verification Standards, and What Distinguishes GenuinePurity's NAD+ Precursor Formulation in an Expanding S ...